Ptpn11 Is A Novel Anti-Fibrotic Gene In Idiopathic Pulmonary Fibrosis

被引：0
|
作者：
Tzouvelekis, A. [1 ,2 ]
Cardenas, C. Lacks Lino [2 ]
Yu, G. [1 ]
Sakamoto, K. [1 ]
DeIuliis, J. [1 ]
Wyllie, A. [3 ]
Ahangari, F. [1 ]
Woolard, T. [1 ]
Heather, L. [1 ]
Herazo-Maya, J. D. [1 ]
Kaminski, N. [1 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Yale Univ, New Haven, CT USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2356
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The efficacy of anti-fibrotic agents for acute exacerbation of idiopathic pulmonary fibrosis
    Matsumoto, Yoko
    Furukawa, Ryutaro
    Ohara, Sayaka
    Usui, Kazuhiro
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [2] DISEASE PROGRESSION IN IDIOPATHIC PULMONARY FIBROSIS UNDER ANTI-FIBROTIC TREATMENT
    Cilli, Aykut
    Uzer, Fatih
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2023, 40 (03)
  • [3] Anti-Fibrotic Therapy and Patient Reported Outcomes in Idiopathic Pulmonary Fibrosis
    Kay, S.
    White, E. S.
    Sheth, J. S.
    Flaherty, C.
    Getty, C.
    Holtze, C.
    Wang, B.
    Salisbury, M.
    Belloli, E.
    Flaherty, K. R.
    Murray, S.
    Xia, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [4] Anti-fibrotic role of inhaled interferon-γ in idiopathic pulmonary fibrosis
    Hasaneen, Nadia
    Tuong Vu
    Fusiak, Timothy
    Foda, Hussein
    Condos, Rany
    Smaldone, Gerald
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [5] Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications
    Nair, Girish B.
    Matela, Ajsza
    Kurbanov, Daniel
    Raghu, Ganesh
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (06) : 699 - 711
  • [6] Factors Affecting The Selection Of Anti-Fibrotic Therapy For Idiopathic Pulmonary Fibrosis
    Kaur, R.
    King, C.
    Brown, A.
    Ahmad, S.
    Shlobin, O. A.
    Weir, N.
    Nathan, S. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [7] A HUMAN MODEL OF LUNG FIBROSIS FOR THE ASSESSMENT OF ANTI-FIBROTIC STRATEGIES IN IDIOPATHIC PULMONARY FIBROSIS
    Roach, K. M.
    Tongue, P.
    Castells, E.
    Elliot, G.
    Marshall, H.
    Richardson, M.
    Mason, S.
    Chachi, L.
    Bradding, P.
    THORAX, 2019, 74 : A56 - A57
  • [8] Real-life survival of idiopathic pulmonary fibrosis with anti-fibrotic medication
    Bleinc, Alexandre
    Blin, Timothee
    Legue, Sylvie
    Mankikian, Julie
    Plantier, Laurent
    Marchand-Adam, Sylvain
    REVUE DES MALADIES RESPIRATOIRES, 2023, 40 (05) : 371 - 381
  • [9] Tolerability and safety of anti-fibrotic agents for idiopathic pulmonary fibrosis in real world
    Sugimoto, Chikatoshi
    Inoue, Yoshikazu
    Arai, Toru
    Kasai, Takehiko
    Akira, Masanori
    Hayashi, Seiji
    Tachibana, Kazunobu
    Sasaki, Yumiko
    Takeuchi, Naoko
    Minomo, Syojiro
    Ikegami, Naoya
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [10] Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy
    Leuschner, Gabriela
    Stocker, Florian
    Veit, Tobias
    Kneidinger, Nikolaus
    Winter, Hauke
    Schramm, Rene
    Weig, Thomas
    Matthes, Sandhya
    Ceelen, Felix
    Arnold, Paola
    Munker, Dieter
    Klenner, Friederike
    Hatz, Rudolf
    Frankenberger, Marion
    Behr, Juergen
    Neurohr, Claus
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (02): : 268 - 274
12345